Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells:: Role of caspase-8 and mitochondria

被引:21
|
作者
Ameyar-Zazoua, M
Larochette, N
Dorothée, G
Daugas, E
Haddada, H
Gouloumet, V
Métivier, D
Stancou, R
Mami-Chouaib, F
Kroemer, G
Chouaib, S
机构
[1] Inst Gustave Roussy, INSERM U487, Lab Cytokines & Immunol Tumeurs Humaines, F-94805 Villejuif, France
[2] Inst Gustave Roussy, CNRS UMR1599, F-94805 Villejuif, France
[3] Inst Gustave Roussy, INSERM U362, F-94805 Villejuif, France
关键词
p53; TNF; mitochondria; caspase-8;
D O I
10.1038/sj.cgt.7700434
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In the present study, we have investigated the mechanisms by which the restoration of wild-type (wt) p53 functions in p53 mutant cells increases their susceptibility to the cytotoxic action of tumor necrosis factor (TNF). Our data indicate that the resistance of p53-mutated cl.1001 cells to TNF-induced cell death was not due to a defect in the expression of TRADD and FADD, yet correlated with a reduced caspase-8 activation as well as a deficient mitochondrial membrane permeabilization. Moreover, cl.1001 cells failed to translocate the mitochondrial AIF and cytochrome c to the nucleus and to the cytosol, respectively, in response to TNF. Sensitization of these cells, following infection with a recombinant adenovirus encoding wtp53, to TNF-induced cytotoxicity resulted in the restoration of caspase-8 cleavage and the reestablishment of mitochondrial signs of apoptosis. These findings suggest that the crosstalk between p53 and TNF-induced cell death depends on mitochondria and that the combination of TNF and Adwtp53 may be a potential strategy to sensitize mutant p53 TNF-resistant tumors to the cytotoxic action of this cytokine.
引用
收藏
页码:219 / 227
页数:9
相关论文
共 50 条
  • [1] Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: Role of caspase-8 and mitochondria
    Maya Ameyar-Zazoua
    Nathanaël Larochette
    Guillaume Dorothée
    Eric Daugas
    Hedi Haddada
    Vanessa Gouloumet
    Didier Métivier
    Rodica Stancou
    Fathia Mami-Chouaib
    Guido Kroemer
    Salem Chouaib
    Cancer Gene Therapy, 2002, 9 : 219 - 227
  • [2] COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION
    MILNER, J
    MEDCALF, EA
    CELL, 1991, 65 (05) : 765 - 774
  • [3] Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53
    Gjerset, RA
    Turla, ST
    Sobol, RE
    Scalise, JJ
    Mercola, D
    Collins, H
    Hopkins, PJ
    MOLECULAR CARCINOGENESIS, 1995, 14 (04) : 275 - 285
  • [4] Activities of wild-type and mutant p53
    Vousden, Karen H.
    CANCER RESEARCH, 2013, 73
  • [5] TUMOR SUPPRESSOR P53 - ANALYSIS OF WILD-TYPE AND MUTANT P53 COMPLEXES
    MILNER, J
    MEDCALF, EA
    COOK, AC
    MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) : 12 - 19
  • [6] Mutant p53: Gain-of-function oncoproteins and wild-type p53 inactivators
    Roemer, K
    BIOLOGICAL CHEMISTRY, 1999, 380 (7-8) : 879 - 887
  • [7] WILD-TYPE P53 INDUCED APOPTOSIS IN A BURKITT-LYMPHOMA (BL) LINE THAT CARRIES MUTANT P53
    RAMQVIST, T
    MAGNUSSON, KP
    WANG, YS
    SZEKELY, L
    KLEIN, G
    WIMAN, KG
    ONCOGENE, 1993, 8 (06) : 1495 - 1500
  • [8] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    A Vinyals
    M A Peinado
    M Gonzalez-Garrigues
    M Monzó
    R D Bonfil
    A Fabra
    Gene Therapy, 1999, 6 : 22 - 33
  • [9] Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
    Palacios, G.
    Moll, U. M.
    ONCOGENE, 2006, 25 (45) : 6133 - 6139
  • [10] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    Vinyals, A
    Peinado, MA
    Gonzalez-Garrigues, M
    Monzó, M
    Bonfil, RD
    Fabra, A
    GENE THERAPY, 1999, 6 (01) : 22 - 33